Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 217
9
Diseases
6
Unique genes
0.393
Avg. similarity score
Encephalopathy
Most-connected disease (7 links)
Disease
Searched: Epileptic encephalopathy, early infantile, 82
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epileptic encephalopathy, early infantile, 82
Encephalopathy
Coma
Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies
Hemiplegic migraine-developmental and epileptic encephalopathy spectrum
Migraine, familial basilar
Neuronal migration disorder with epilepsy
Benign familial infantile convulsions
Early-onset dystonia with spastic paraplegia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Encephalopathy | 7 | 7 | 5 |
| Coma | 6 | 6 | 1 |
| Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies | 6 | 6 | 1 |
| Hemiplegic migraine-developmental and epileptic encephalopathy spectrum | 6 | 6 | 1 |
| Migraine, familial basilar | 6 | 6 | 1 |
| Neuronal migration disorder with epilepsy | 6 | 6 | 1 |
| Benign familial infantile convulsions | 5 | 5 | 1 |
| Early-onset dystonia with spastic paraplegia | 1 | 1 | 2 |
| Epileptic encephalopathy, early infantile, 82 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATP1A2 | 7 / 9 | Benign familial infantile convulsions, Coma, Encephalopathy, Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies and 3 more |
| GOT2 | 2 / 9 | Encephalopathy, Epileptic encephalopathy, early infantile, 82 |
| PTPN1 | 2 / 9 | Early-onset dystonia with spastic paraplegia, Encephalopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| PTK6 Down-Regulation | Reactome | 1 / 3 | 667× | 1.50e-3 | 1.54e-2 ✓ sig. |
| MECP2 regulates neuronal receptors and channels | Reactome | 1 / 4 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Phenylalanine, tyrosine and tryptophan biosynthesis | KEGG | 1 / 6 | 334× | 2.99e-3 | 2.54e-2 ✓ sig. |
| Chemical carcinogenesis - reactive oxygen species | KEGG | 2 / 227 | 17.6× | 5.07e-3 | 3.68e-2 ✓ sig. |
| Thermogenesis | KEGG | 2 / 234 | 17.1× | 5.38e-3 | 3.83e-2 ✓ sig. |
| Aspartate and asparagine metabolism | Reactome | 1 / 12 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| Growth hormone receptor signaling | Reactome | 1 / 14 | 143× | 6.98e-3 | 4.53e-2 ✓ sig. |
| Glutamate and glutamine metabolism | Reactome | 1 / 14 | 143× | 6.98e-3 | 4.53e-2 ✓ sig. |
| Phenylalanine metabolism | KEGG | 1 / 16 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
| Formation of ATP by chemiosmotic coupling | Reactome | 1 / 18 | 111× | 8.96e-3 | 5.31e-2 |
| Cristae formation | Reactome | 1 / 18 | 111× | 8.96e-3 | 5.31e-2 |
| Negative regulation of MET activity | Reactome | 1 / 21 | 95.3× | 1.04e-2 | 5.84e-2 |
| Arginine biosynthesis | KEGG | 1 / 23 | 87.0× | 1.14e-2 | 6.18e-2 |
| Proximal tubule bicarbonate reclamation | KEGG | 1 / 23 | 87.0× | 1.14e-2 | 6.18e-2 |
| Integrin signaling | Reactome | 1 / 23 | 87.0× | 1.14e-2 | 6.18e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| olfactory cortex development | GO:0021989 | 1 / 1 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| regulation of glutamate uptake involved in transmission of nerve impulse | GO:0051946 | 1 / 2 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| L-glutamate catabolic process to aspartate | GO:0019550 | 1 / 2 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| regulation of hepatocyte growth factor receptor signaling pathway | GO:1902202 | 1 / 2 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| negative regulation of striated muscle contraction | GO:0045988 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| negative regulation of calcium ion transmembrane transport | GO:1903170 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| aspartate biosynthetic process | GO:0006532 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| L-aspartate catabolic process | GO:0006533 | 1 / 3 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| trans-4-hydroxy-L-proline catabolic process | GO:0019470 | 1 / 4 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| amygdala development | GO:0021764 | 1 / 4 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| insulin receptor recycling | GO:0038020 | 1 / 4 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| proton transmembrane transport | GO:1902600 | 2 / 181 | 34.4× | 1.36e-3 | 1.74e-2 ✓ sig. |
| negative regulation of translation in response to stress | GO:0032055 | 1 / 5 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| regulation of type I interferon-mediated signaling pathway | GO:0060338 | 1 / 5 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| L-glutamate catabolic process | GO:0006538 | 1 / 5 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |